Jiaogulan is an East Asian climbing plant used as an oral tea or supplement extract for blood sugar control, fat loss, and endurance. In short-term human trials, leaf tea lowers elevated blood sugar and insulin resistance, while heat-processed extract modestly reduces abdominal and hip fat and improves endurance. Cholesterol and liver enzyme benefits occur mainly as an add-on, and rare reversible blood cell drops warrant monitoring. (Full Review)
| Marker | Target | Why |
|---|---|---|
| Fasting Plasma Glucose | 3.9–5.5 mmol/L (70–99 mg/dL) | Efficacy marker (expected to decrease in insulin resistance) and safety check for hypoglycemia |
| HbA1c | <5.7% | Efficacy marker (expected to decrease over 8–12 weeks in elevated states) |
| Serum Triglycerides | <1.7 mmol/L (<150 mg/dL) | Efficacy marker (expected to decrease via AMPK and FXR hepatic lipid oxidation) |
| Serum HDL-C | >1.0 mmol/L men, >1.3 mmol/L women | Efficacy marker (generally increases) and safety check in CETP B2 / non-APOE4 carriers (discontinuation threshold: >10% drop) |
| Platelet & Leukocyte Count (CBC) | Platelets 150–450 × 109/L; WBC 4.5–11.0 × 109/L | Safety check for thrombocytopenia or leukopenia (discontinuation threshold: platelets <150 × 109/L) |
| Liver Enzymes (ALT, AST, ALP) | ALT 7–56 U/L; AST 8–33 U/L; ALP 44–147 U/L | Efficacy marker in fatty liver disease and baseline safety check |
| Visceral & Total Fat Mass (DEXA) | No established target; reduction from individual baseline | Efficacy marker (expected to decrease over 12–16 weeks with damulin-standardized extract) |
Cadence: Baseline (fasting glucose, fasting insulin/HOMA-IR, HbA1c, lipid panel including triglycerides/HDL-C/LDL-C, CBC with differential and platelets, ALT/AST/ALP, and optional DEXA scan), 4 weeks (fasting glucose, HDL-C, platelets), 12–16 weeks (HbA1c, triglycerides, liver enzymes, repeat DEXA), and every 6 months during continued use.